MNV-201

N/A

Report date: 2024/06/19 20:00:11

Base Information

Drug NameMNV-201
Drug Alias NameAutologous CD34+ Cells Enriched with allogenic Placenta Derived Mitochondria therapy(Minovia Therapeutics)MNV-201
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionMitochondrial proteins modulators
TargetsMitochondrial proteins
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMinovia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMinovia Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A